Application 761382
- Type
- BLA
- Sponsor
- SANDOZ INC
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761382 | Enzeevu | aflibercept-abzv | 351(k) Interchangeable | Rx | 2026-10-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ENZEEVU | AFLIBERCEPT-ABZV | INJECTABLE;INJECTION | 2MG(0.05ML of 40MG/ML) | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ENZEEVU | AFLIBERCEPT | Sandoz Inc | 6f1d28a8-1c10-40d2-83f0-6a528f807b92 | 2026-04-24 | Warnings, Adverse reactions | BLA761382 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.